PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies

Marcelle Silva-Abreu,1,2 Ana Cristina Calpena,1,2 Pol Andrés-Benito,3,4 Ester Aso,3,4 Ignacio A Romero,5 David Roig-Carles,5 Radka Gromnicova,5 Marta Espina,1,2 Isidre Ferrer,3,4 María Luisa García,1,2 David Male5 1Department of Pharmacy, Pharmaceutical Technology a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Silva-Abreu M, Calpena AC, Andrés-Benito P, Aso E, Romero IA, Roig-Carles D, Gromnicova R, Espina M, Ferrer I, García ML, Male D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Nanoparticle
Alzheimer’s disease
Blood brain barrier
Brain endothelium
Pioglitazone
APP/PS1 transgenic mouse.
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/2417f5fa9d024b44a02f84dea736322c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/2417f5fa9d024b44a02f84dea736322c

Ejemplares similares